Colgate-Palmolive Company is a household & personal products business based in the US. Colgate-Palmolive Company shares (CL) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $93.91 – an increase of 2.69% over the previous week. Colgate-Palmolive Company employs 34,000 staff and has a trailing 12-month revenue of around $20.1 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $93.91 |
|---|---|
| 52-week range | $73.55 - $108.76 |
| 50-day moving average | $99.60 |
| 200-day moving average | $94.99 |
| Wall St. target price | $105.23 |
| PE ratio | 26.2034 |
| Dividend yield | $1.96 (2.2%) |
| Earnings per share (TTM) | $3.49 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $93.61 from 2024-11-19
| 1 week (2024-11-14) | 2.36% |
|---|---|
| 1 month (2024-10-21) | -5.79% |
| 3 months (2024-08-21) | -9.53% |
| 6 months (2024-05-21) | -1.64% |
| 1 year (2023-11-21) | 22.25% |
|---|---|
| 2 years (2022-11-21) | 27.60% |
| 3 years (2021-11-19) | 30.21% |
| 5 years (2019-11-21) | 57.70% |
Valuing Colgate-Palmolive Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Colgate-Palmolive Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Colgate-Palmolive Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 26x. In other words, Colgate-Palmolive Company shares trade at around 26x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Colgate-Palmolive Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0569. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Colgate-Palmolive Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Colgate-Palmolive Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.9 billion.
The EBITDA is a measure of a Colgate-Palmolive Company's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $20.1 billion |
|---|---|
| Operating margin TTM | 21% |
| Gross profit TTM | $10.2 billion |
| Return on assets TTM | 16.33% |
| Return on equity TTM | 48.79% |
| Profit margin | 14.26% |
| Book value | $0.53 |
| Market Capitalization | $74.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 55.77% of net profits
Recently Colgate-Palmolive Company has paid out, on average, around 100% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Colgate-Palmolive Company shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Colgate-Palmolive Company's case, that would currently equate to about $1.96 per share.
Colgate-Palmolive Company's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Colgate-Palmolive Company's most recent dividend payout was on 14 November 2024. The latest dividend was paid out to all shareholders who bought their shares by 17 October 2024 (the "ex-dividend date").
Colgate-Palmolive Company's shares were split on a 2:1 basis on 15 May 2013 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Colgate-Palmolive Company shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Colgate-Palmolive Company shares which in turn could have impacted Colgate-Palmolive Company's share price.
Over the last 12 months, Colgate-Palmolive Company's shares have ranged in value from as little as $73.548 up to $108.7564. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Colgate-Palmolive Company's is 0.415. This would suggest that Colgate-Palmolive Company's shares are less volatile than average (for this exchange).
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, and Soupline to a range of traditional and eCommerce retailers, wholesalers, and distributors. It includes pharmaceutical products for dentists and other oral health professionals. Its Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.